Haiti vs South Sudan: HIV/AIDS deaths averted by antiretroviral therapy
Haiti
8,513 deaths
in 2024
South Sudan
6,931 deaths
in 2024
Haiti rank
27th
South Sudan rank
29th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Haiti
- South Sudan
How they compare
Haiti currently reports 8,513 deaths against 6,931 deaths in South Sudan, a difference of 1,582 deaths.
That makes Haiti's figure about 1.2 times South Sudan's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was South Sudan ahead.
Haiti ranks 27th and South Sudan ranks 29th of 157 countries.
Haiti has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Haiti | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 1,003 deaths | 53.17 deaths | 949.81 deaths | Haiti |
| 2010s | 4,307 deaths | 2,048 deaths | 2,259 deaths | Haiti |
| 2020s | 8,123 deaths | 5,394 deaths | 2,729 deaths | Haiti |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Haiti or South Sudan?
- Haiti, at 8,513 deaths against 6,931 deaths in South Sudan as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Haiti and South Sudan?
- 1,582 deaths, with Haiti ahead.
- How many years of comparable data are there for Haiti and South Sudan?
- 35 years are reported by both, from 1990 to 2024.
- How do Haiti and South Sudan rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Haiti ranks 27th and South Sudan ranks 29th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.